Not exact matches
«We've been hearing about their potential
for more than a decade, but the results have always been in mice and rats, and no one has shown they're
safe or effective in
humans long term,» says Robert Lanza of Advanced
Cell Technology in Marlborough, Massachusetts, the company that carried out the stem cell intervent
Cell Technology in Marlborough, Massachusetts, the company that carried out the stem
cell intervent
cell intervention.
«Does that mean that people are getting access to
safe and efficacious interventions or is there basically unapproved
human experimentation taking place where people are going to these businesses and receiving experimental investigational
cell - based interventions without being given a meaningful account of the lack of knowledge and evidence that they're being charged
for?»
This method and such piPS
cells provide
safer cells for personalized regenerative medicine and more effective platform
for human disease modeling.
Allogeneic Mesenchymal Stem
Cells Stimulate Cartilage Regeneration and Are
Safe for Single - Stage Cartilage Repair in
Humans upon Mixture with Recycled Autologous Chondrons.
Targeted Gene Addition to a
Safe Harbor locus in
human CD34 + Hematopoietic Stem
Cells for Correction of X-linked Chronic Granulomatous Disease.
«In a report published in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced
Cell Technology, provide the first evidence that stem
cells from
human embryos can be a
safe and effective source of therapies
for two types of eye diseases»
While these valves are
safe and effective, their manufacturing remains complex and expensive as
human cells must be cultured
for a long time under heavily regulated conditions.
The symposium will also explore and discuss the challenges that lie ahead
for those seeking to develop
safe stem
cell - based
human therapies.
These same challenges exist
for human allergy suffers, but recently there has been a major breakthrough in the development of a new,
safe and effective therapy using a monoclonal antibody that specifically binds and neutralizes
human IgE that is responsible
for activating inflammation - producing
cells.